BCM
ACHN

Bluefin Capital Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Bluefin Capital Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-23,327
Closed -$233K – 997
2014
Q3 		$233K Buy
+23,327
New +$217K 0.01% 550

Bluefin Capital Management's ACHN Position: Q4 2014 in Review

Bluefin Capital Management sold out of Achillion Pharmaceuticals (ACHN) in Q4 2014, closing a stake of 23,327 shares — an estimated $233K sold.

Bluefin Capital Management first reported a position in ACHN in Q3 2014 and held it in 1 quarter. The position peaked at $233K in Q3 2014. 179 funds tracked by Wall St. Rank hold ACHN as of Q4 2014.

  • Bluefin Capital Management reported no remaining Achillion Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Bluefin Capital Management sold 23,327 Achillion Pharmaceuticals shares in Q4 2014, an estimated $233K.
  • Bluefin Capital Management first reported a position in Achillion Pharmaceuticals in Q3 2014 and held it in 1 quarter.
  • Bluefin Capital Management's Achillion Pharmaceuticals position peaked at $233K in Q3 2014.
  • 179 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2014.

Based on Bluefin Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.